Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,647,590
-$683,581 QoQ
Shares Held
151,478
-1.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#730
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECURIAN ASSET MANAGEMENT, INC holds $78,680,706 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,012 | $25,202,425 | |
| 2 | JNJ |
Johnson & Johnson
|
63,968 | $16,245,952 | |
| 3 | ABBV |
AbbVie Inc.
|
46,949 | $11,814,246 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,631 | $8,433,583 | |
| 5 | AMGN |
Amgen Inc
|
14,346 | $5,194,973 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
32,954 | $4,163,408 | |
| 7 | PFE |
Pfizer Inc
This page
|
151,478 | $3,647,590 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
54,255 | $3,126,173 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,647,590 | 151,478 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,331,171 | 154,244 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,849,664 | 154,605 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,996,272 | 274,579 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,205,291 | 297,248 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,606,814 | 300,190 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $8,080,401 | 304,576 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,070,230 | 313,415 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,116,807 | 325,833 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $9,228,845 | 332,571 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $10,295,476 | 357,606 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $13,439,289 | 405,164 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $17,382,762 | 473,903 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $19,441,730 | 476,513 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $24,315,532 | 474,542 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $20,472,590 | 467,838 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $24,412,980 | 465,630 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $24,262,321 | 468,656 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $28,045,088 | 474,938 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $20,121,110 | 467,824 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $18,487,279 | 472,096 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $17,141,681 | 473,135 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $17,938,359 | 487,323 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $18,562,437 | 505,789 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $16,703,209 | 510,801 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $17,674,209 | 541,490 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||